Genetic Testing for Prostate Cancer

Many cancers, including prostate cancer, can either develop from an acquired gene mutation (non-hereditary), or a hereditary gene mutation. Although most instances of prostate cancer are thought to be non-hereditary, there is always the chance of prostate cancer resulting from a hereditary gene mutation.

What is Genetic Testing for Prostate Cancer?

Genetic testing for prostate cancer is a specific type of medical testing that looks for and identifies mutations in certain genes to determine whether or not an individual is at an increased risk of developing prostate cancer based on his genetic make-up. There are four genes that are identified as being linked to prostate cancer and analyzed as a part of genetic testing. These genes are:

  • BRCA1
  • BRCA2
  • ATM
  • CHEK2
  • And More.

Genetic testing for prostate cancer can also give valuable insight as to whether there is a mutation that can be passed on to offspring.

Who Should Get Genetic Testing for Prostate Cancer?

It is estimated that 5-10 percent of diagnosed prostate cancers are hereditary. If you meet one or more of the following criteria, you may want to consider genetic testing for prostate cancer for both you and your family.

  • Men who have been diagnosed with localized prostate cancer (cancer confined to the prostate)
  • At least one relative with breast or ovarian cancer who was diagnosed before the age of 50
  • Two or more family members who have been diagnosed with breast, ovarian, or late-stage prostate cancer at any age.
  • Men who have been diagnosed with metastatic prostate cancer (cancer that has spread to other parts of the body)
  • Men with at least one relative who has tested positive for a gene mutation known to be associated with an increased risk for prostate cancer

Our High Risk Cancer Assessment program is available to our patients. This specialized team can help you get access to genetic testing and counseling, if needed.